Get started
Author

Cameron N. Johnstone

Observed names: C N Johnstone, C. Johnstone, C.N. Johnstone, Cameron Johnstone, Cameron Johnstone (14922419), Cameron N Johnstone, Cameron N. Johnstone
Observed institutions: Cleveland Clinic, The Royal Melbourne Hospital, Memorial Sloan Kettering Cancer Center, University of Wisconsin–Madison, Oregon Health & Science University, The University of Melbourne, Ludwig Cancer Research, La Trobe University, QIMR Berghofer Medical Research Institute, Brown University, Peter MacCallum Cancer Centre, Starpharma (Australia), Victorian Comprehensive Cancer Centre, Ludwig Cancer Research, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Stanford Medicine, Ludwig Cancer Research, Olivia Newton-John Cancer Wellness & Research Centre, Abramson Cancer Center, Olivia Newton-John Cancer Research Institute, Cleveland Clinic Research, Monash University, Monash Institute of Medical Research, University of Pennsylvania, Stanford University
ORCID: 0000-0002-6464-8661
Observed ORCID: 0000-0002-6464-8661
OpenAlex ID: A5077935453
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
2008 · Lin Zhang, Stefano Volinia, et al. · Proceedings of the National Academy of Sciences · 522
PDF
MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
2008 · Nuo Yang, Sippy Kaur, et al. · Cancer Research · 364
PDF
Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer
2015 · Cameron N. Johnstone, Yvonne E. Smith, et al. · Disease Models & Mechanisms · 218
PDF
Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers
2011 · Åslaug Helland, Michael S. Anglesio, et al. · PLoS ONE · 216
PDF
The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily
1997 · Joan K. Heath, Sara J. White, et al. · Proceedings of the National Academy of Sciences · 188
The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation
2007 · Takaomi Okawa, Carmen Z. Michaylira, et al. · Genes & Development · 174
PDF
BMP4 Inhibits Breast Cancer Metastasis by Blocking Myeloid-Derived Suppressor Cell Activity
2014 · Yuan Cao, Clare Y. Slaney, et al. · Cancer Research · 138
MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways
2013 · X Li, S Roslan, et al. · Oncogene · 127
LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms
2011 · C E King, L Wang, et al. · Oncogene · 127
PDF
IMP-1 Displays Cross-Talk with K-Ras and Modulates Colon Cancer Cell Survival through the Novel Proapoptotic Protein CYFIP2
2011 · Perry S. Mongroo, Felicite K. Noubissi, et al. · Cancer Research · 123
PDF
Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer
2015 · Cameron N. Johnstone, Ashwini Chand, et al. · Cytokine & Growth Factor Reviews · 122
PDF
Annexin‐1 signals mitogen‐stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2
2010 · Thippadey Khau, Shenna Y. Langenbach, et al. · The FASEB Journal · 110
Subtypes of familial breast tumours revealed by expression and copy number profiling
2009 · kConFab Investigators, Nic Waddell, et al. · Breast Cancer Research and Treatment · 103
DNA Methylome of Familial Breast Cancer Identifies Distinct Profiles Defined by Mutation Status
2010 · James M. Flanagan, Sibylle Cocciardi, et al. · The American Journal of Human Genetics · 85
PDF
Characterization of mouse A33 antigen, a definitive marker for basolateral surfaces of intestinal epithelial cells
2000 · Cameron N. Johnstone, Niall C. Tebbutt, et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 71
MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms
2022 · Lap Hing Chi, Ryan S. N. Cross, et al. · Oncogenesis · 68
PDF
β-parvin inhibits integrin-linked kinase signaling and is downregulated in breast cancer
2004 · Perry S Mongroo, Cameron N Johnstone, et al. · Oncogene · 64
ARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHOGAP: mutation and expression analyses in colorectal and breast cancers
2004 · Cameron N. Johnstone, Sergi Castellvı́-Bel, et al. · Gene · 64
Ha-RasG12V induces senescence in primary and immortalized human esophageal keratinocytes with p53 dysfunction
2004 · Munenori Takaoka, Hideki Harada, et al. · Oncogene · 57
TGF-βRII Rescues Development of Small Intestinal Epithelial Cells in Elf3-Deficient Mice
2007 · Nicole Flentjar, Po–Yin Chu, et al. · Gastroenterology · 47
Parvin-β Inhibits Breast Cancer Tumorigenicity and Promotes CDK9-Mediated Peroxisome Proliferator-Activated Receptor Gamma 1 Phosphorylation
2007 · Cameron N. Johnstone, Perry S. Mongroo, et al. · Molecular and Cellular Biology · 44
Analysis of the Regulation of the A33 Antigen Gene Reveals Intestine-specific Mechanisms of Gene Expression
2002 · Cameron N. Johnstone, Sara J. White, et al. · Journal of Biological Chemistry · 44
FGF13 promotes metastasis of triple‐negative breast cancer
2020 · Cameron N. Johnstone, Andrew D. Pattison, et al. · International Journal of Cancer · 36
Annexin A1 influences in breast cancer: Controversies on contributions to tumour, host and immunoediting processes
2017 · Yan Tu, Cameron N. Johnstone, et al. · Pharmacological Research · 35
N-Cadherin and Keratinocyte Growth Factor Receptor Mediate the Functional Interplay between Ki-RASG12V and p53V143A in Promoting Pancreatic Cell Migration, Invasion, and Tissue Architecture Disruption
2006 · Therese B. Deramaudt, Munenori Takaoka, et al. · Molecular and Cellular Biology · 33
PDF
Works count: 94
Citation count: 3,501
H-index: 30
I10-index: 37
Year
Topic
Type